Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-01 6:34 pm Sale | 13D | DIANTHUS THERAPEUTICS INC DNTH | Fairmount Funds Management LLC | 2,957,385 9.99% | -3,362 (-0.11%) | View |
| 2024-02-14 4:58 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | CITADEL ADVISORS LLC | 2,880 0% | 2,880 (New Position) | View |
| 2024-02-14 4:16 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | 5AM Partners VII LLC | 1,682,584 5.7% | 200,264 (+13.51%) | View |
| 2024-02-14 4:15 pm Unchanged | 13G | DIANTHUS THERAPEUTICS INC DNTH | Third Rock Ventures IV L.P. | 0 0% | 0 (Unchanged) | View |
| 2024-02-09 4:10 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | GV 2016 L.P. | 208,697 1.4% | 208,697 (New Position) | View |
| 2024-02-02 4:32 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | BCLS Fund III Investments LP | 2,992,028 9.99% | 2,992,028 (New Position) | View |
| 2024-02-01 6:22 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | RA CAPITAL MANAGEMENT L.P. | 2,995,023 9.99% | 2,995,023 (New Position) | View |
| 2024-01-31 12:11 pm Purchase | 13D | DIANTHUS THERAPEUTICS INC DNTH | Avidity Partners Management LP | 2,922,823 9.9% | 2,922,823 (New Position) | View |
| 2024-01-24 5:26 pm Purchase | 13D | DIANTHUS THERAPEUTICS INC DNTH | Fairmount Funds Management LLC | 2,960,747 9.9% | 1,086,914 (+58.00%) | View |
| 2023-11-13 09:02 am Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | FMR LLC | 2,218,212 14.97% | 2,218,212 (New Position) | View |
| 2023-09-21 4:34 pm Purchase | 13D | DIANTHUS THERAPEUTICS INC DNTH | Viridian LLC | 1,090,283 7.4% | 1,090,283 (New Position) | View |
| 2023-09-21 4:32 pm Purchase | 13D | DIANTHUS THERAPEUTICS INC DNTH | Fairmount Funds Management LLC | 1,873,833 12.7% | 1,873,833 (New Position) | View |
| 2023-09-21 4:15 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | 5AM Partners VII LLC | 1,482,320 10% | 1,482,320 (New Position) | View |
| 2023-09-21 4:15 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | Venrock Healthcare Capital Partners III L.P. | 927,706 6.3% | 927,706 (New Position) | View |
| 2023-09-15 4:56 pm Purchase | 13D | DIANTHUS THERAPEUTICS INC DNTH | Atlas Venture Fund X L.P. | 186,089 1.3% | 186,089 (New Position) | View |
| 2023-05-15 4:47 pm Purchase | 13G | MAGENTA THERAPEUTICS INC MGTA | CITADEL ADVISORS LLC | 4,087,110 6.7% | 4,087,110 (New Position) | View |
| 2023-02-14 4:45 pm Sale | 13G | MAGENTA THERAPEUTICS INC MGTA | RA CAPITAL MANAGEMENT L.P. | 0 0% | -3,588,081 (Position Closed) | View |
| 2023-02-14 11:12 am Sale | 13G | MAGENTA THERAPEUTICS INC MGTA | Aquilo Capital Management LLC | 0 0% | -3,155,082 (Position Closed) | View |
| 2023-02-14 08:47 am Sale | 13G | MAGENTA THERAPEUTICS INC MGTA | Deep Track Capital LP | 3,000,000 4.95% | -1,870,000 (-38.40%) | View |
| 2023-02-14 06:09 am Sale | 13G | MAGENTA THERAPEUTICS INC MGTA | GILDER GAGNON HOWE & CO LLC | 425,858 0.7% | -3,249,750 (-88.41%) | View |